LISA HALL: Open Payments
NPI 1114945953 · SANFORD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,471 in 69 payments from 17 companies in 2025. Trend: 2023 $1,367 · 2024 $1,375 · 2025 $1,471
Food & beverage: $1,471
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $395 |
| Janssen Biotech, Inc. | 10 | $271 |
| Ardelyx, Inc. | 8 | $166 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $93 |
| Regeneron Healthcare Solutions, Inc. | 3 | $87 |
| Aimmune Therapeutics, Inc. | 3 | $66 |
| Ipsen Biopharmaceuticals, Inc | 2 | $60 |
| Gilead Sciences, Inc. | 2 | $50 |
| Lilly USA, LLC | 2 | $43 |
| Madrigal Pharmaceuticals | 2 | $41 |
Products named: TREMFYA, RINVOQ, IBSRELA, DUPIXENT, ZENPEP, EOHILIA, IQIRVO, LINZESS.
Industry payments across NC — which companies pay providers there.
